Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -518.25% |
| Dec 31, 2025 | -53.91% |
| Sep 30, 2025 | 25.61% |
| Jun 30, 2025 | -38.87% |
| Mar 31, 2025 | 15.09% |
| Dec 31, 2024 | -8.99% |
| Sep 30, 2024 | 12.02% |
| Jun 30, 2024 | 42.40% |
| Mar 31, 2024 | -128.27% |
| Dec 31, 2023 | 4.40% |
| Sep 30, 2023 | -19.64% |
| Jun 30, 2023 | 15.40% |
| Mar 31, 2023 | -9.83% |
| Dec 31, 2022 | -19.74% |
| Sep 30, 2022 | 6.52% |
| Jun 30, 2022 | -5.03% |
| Mar 31, 2022 | -45.10% |
| Dec 31, 2021 | 1.59% |
| Sep 30, 2021 | 0.79% |
| Jun 30, 2021 | -12.72% |
| Mar 31, 2021 | 16.15% |
| Dec 31, 2020 | -13.59% |
| Sep 30, 2020 | -22.48% |
| Jun 30, 2020 | 7.25% |
| Mar 31, 2020 | -10.73% |
| Dec 31, 2019 | 34.06% |
| Sep 30, 2019 | -65.63% |
| Jun 30, 2019 | -16.09% |
| Mar 31, 2019 | 59.41% |
| Dec 31, 2018 | -447.76% |
| Sep 30, 2018 | 46.66% |
| Jun 30, 2018 | 2.68% |
| Mar 31, 2018 | -34.51% |
| Dec 31, 2017 | -199.10% |
| Sep 30, 2017 | 90.31% |
| Jun 30, 2017 | -147.72% |
| Mar 31, 2017 | 65.83% |
| Dec 31, 2016 | -164.70% |
| Sep 30, 2016 | 43.48% |
| Jun 30, 2016 | -31.28% |